000 01691 a2200493 4500
005 20250516194528.0
264 0 _c20141028
008 201410s 0 0 eng d
022 _a1791-2431
024 7 _a10.3892/or.2014.3009
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aChiang, I-Tsang
245 0 0 _aCurcumin synergistically enhances the radiosensitivity of human oral squamous cell carcinoma via suppression of radiation-induced NF-κB activity.
_h[electronic resource]
260 _bOncology reports
_cApr 2014
300 _a1729-37 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Agents
_xadministration & dosage
650 0 4 _aBlotting, Western
650 0 4 _aCarcinoma, Squamous Cell
_xmetabolism
650 0 4 _aCell Line, Tumor
650 0 4 _aCombined Modality Therapy
650 0 4 _aCurcumin
_xadministration & dosage
650 0 4 _aElectrophoretic Mobility Shift Assay
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMice
650 0 4 _aMice, Inbred NOD
650 0 4 _aMice, SCID
650 0 4 _aMouth Neoplasms
_xmetabolism
650 0 4 _aNF-kappa B
650 0 4 _aRadiation Tolerance
_xdrug effects
650 0 4 _aTransfection
650 0 4 _aXenograft Model Antitumor Assays
700 1 _aLiu, Yu-Chang
700 1 _aHsu, Fei-Ting
700 1 _aChien, Yi-Chun
700 1 _aKao, Chih-Hao K
700 1 _aLin, Wuu-Jyh
700 1 _aChung, Jing-Gung
700 1 _aHwang, Jeng-Jong
773 0 _tOncology reports
_gvol. 31
_gno. 4
_gp. 1729-37
856 4 0 _uhttps://doi.org/10.3892/or.2014.3009
_zAvailable from publisher's website
999 _c23523124
_d23523124